Local lymph node assay with non-radioisotope alternative endpoints

Area of Science:

• Toxicology
• Immunology
• Dermatology

Background:

• The local lymph node assay (LLNA) is a regulatory-accepted method for predicting allergic contact dermatitis.
• Non-radioisotope alternatives to the standard LLNA are being developed to improve safety and accessibility.

Purpose of the Study:

• To compare the sensitivity of non-radioisotope methods with the standard radioisotope-based LLNA.
• To evaluate if modified non-radioisotope methods affect the assessment of chemical sensitization potency.

Main Methods:

• CBA mice were treated with 2,4-dinitrochlorobenzene (DNCB) or benzocaine.
• Lymph node proliferative activity was assessed using 3H-methyl thymidine (3H-TdR), bromodeoxyuridine (BrdU) in vivo and ex vivo, IL-2 production, and proliferating cell nuclear antigen (PCNA) expression.
• Ear thickness was also measured.

Main Results:

• The strong sensitizer DNCB was detected by both non-radioisotope methods and the standard assay.
• Weak sensitizer benzocaine showed significant changes with ex vivo/in vivo BrdU incorporation and IL-2 production.
• Non-radioisotope methods demonstrated comparable or enhanced sensitivity for detecting sensitization.

Conclusions:

• Non-radioisotope methods are viable alternatives for assessing allergic contact dermatitis.
• These methods can accurately evaluate sensitization potency for both strong and weak sensitizers.
• Non-radioisotope assays offer a practical solution for laboratories where handling radioisotopes is challenging.